Julie Y. Crider - Concepedia

Author

Julie Y. Crider

Also Known As

Crider, Julie Y., J Y Crider, J.Y. CRIDER, J.Y. Crider, JULIE Y. CRIDER, Julie Crider, Julie Y Crider, Julie Y. CRIDER, Julie Y. Crider

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Alcon (United States)Alcon (China)

About

Julie Y. Crider is an author at Alcon (United States) specializing in medicine, pharmacology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	445
2	Biochemistry	4	4	378
3	Cell Biology	3	3	215
4	Natural Sciences	1	1	159
5	Cellular Physiology	1	1	22

Julie Y. Crider

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Ocular Hypotensive FP Prostaglandin (PG) Analogs: PG Receptor Subtype Binding Affinities and Selectivities, and Agonist Potencies at FP and Other PG Receptors in Cultured Cells Najam A. Sharif, Curtis R. Kelly, Julie Y. Crider, Journal of Ocular Pharmacology and Therapeutics Ocular DiseaseMedicinal ChemistryRetinaAgonist PotenciesBimatoprost Acid	2003	159
Human Trabecular Meshwork Cell Responses Induced by Bimatoprost, Travoprost, Unoprostone, and other FP Prostaglandin Receptor Agonist Analogues Najam A. Sharif, Curtis R. Kelly, Julie Y. Crider Investigative Ophthalmology & Visual Science	2003	122
AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. Brenda Walker Griffin, Peter G. Klimko, Julie Y. Crider, PubMed PharmacotherapyExperimental PharmacologyProstaglandin FInflammationMolecular Pharmacology	1999	101
Agonist Activity of Bimatoprost, Travoprost, Latanoprost, Unoprostone Isopropyl Ester and Other Prostaglandin Analogs at the Cloned Human Ciliary Body FP Prostaglandin Receptor Najam A. Sharif, Curtis R. Kelly, Julie Y. Crider Journal of Ocular Pharmacology and Therapeutics ImmunologyPharmacotherapyExperimental PharmacologyFp Prostaglandin ReceptorOther Prostaglandin Analogs	2002	97
Human Ciliary Muscle Cell Responses to FP-Class Prostaglandin Analogs: Phosphoinositide Hydrolysis, Intracellular Ca <sup>2+</sup> Mobilization and MAP Kinase Activation Naj Sharif, Julie Y. Crider, Shahid Husain, Journal of Ocular Pharmacology and Therapeutics	2003	64
FP Prostaglandin Receptors Mediating Inositol Phosphates Generation and Calcium Mobilization in Swiss 3T3 Cells: A Pharmacological Study Brenda Walker Griffin, Gary W. Williams, Julie Y. Crider, Journal of Pharmacology and Experimental Therapeutics	1997	63
AL-8810: A Novel Prostaglandin F2α Analog with Selective Antagonist Effects at the Prostaglandin F2α (FP) Receptor Brenda Walker Griffin, Peter G. Klimko, Julie Y. Crider, Journal of Pharmacology and Experimental Therapeutics	1999	60
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists Julie Y. Crider, Brenda Walker Griffin, Najam A. Sharif British Journal of Pharmacology	1999	53
Affinities, Selectivities, Potencies, and Intrinsic Activities of Natural and Synthetic Prostanoids Using Endogenous Receptors: Focus on DP Class Prostanoids Najam A. Sharif, Julie Y. Crider, Shouxi Xu, Journal of Pharmacology and Experimental Therapeutics	2000	48
Levobetaxolol (Betaxon™) and Other <i>β</i> -Adrenergic Antagonists: Preclinical Pharmacology, IOP-Lowering Activity and Sites of Action in Human Eyes Najam A. Sharif, Shouxi Xu, Julie Y. Crider, Journal of Ocular Pharmacology and Therapeutics	2001	47

Page 1